Therapeutic goods, specifically medical devices, are vital in modern healthcare. The products must meet strict safety, quality, and efficacy (performance) standards before being available to patients. In Australia, the Therapeutic Goods Administration (TGA) applies a risk management approach to regulating all therapeutic goods, including medical devices. The TGA can ensure their safety and effectiveness through the Therapeutic Goods Act 1989 (the Act).
A critical step in the regulatory process is the pre-market assessment by the TGA, which is a thorough evaluation of a medical device’s performance and safety.
This article will provide an overview of market authorisation via TGA pre-market assessment, outlining the steps involved in the assessment process and the key requirements that medical device manufacturers and sponsors must meet.
What Is the Pre-Market Assessment?
The pre-market assessment by the TGA is the stage wherein they will acquire the information necessary to decide whether to register, list, or include therapeutic goods on the Australian Register of Therapeutic Goods (ARTG). To do so, they accept assessment certifications, evaluate the information from sponsors or manufacturers, or conduct direct inspections.
Pre-Market Assessment of Medical Devices
The TGA classifies medical devices into different classes based on their level of risk to patients. The pre-market assessment involves various levels of scrutiny by the TGA of a device depending on the risk it poses to patients and its intended use.
Class I medical devices, considered to pose the lowest risk, are subject to self-assessment by the manufacturer. The manufacturer ensures the device meets the Essential Principles for Safety and Performance outlined in the Australian regulatory framework. The TGA conducts random checks to ensure compliance, but pre-market clearance or registration is unnecessary.
Class III medical devices, on the other hand, which are considered to pose the highest risk, undergo the most stringent pre-market assessment. Manufacturers must provide comprehensive technical documentation and clinical evidence to demonstrate safety and performance.
The TGA thoroughly evaluates this evidence and may require additional information, such as expert opinions or clinical trial data, before registering. Class III medical devices also require conformity assessment by a third-party organisation.
Market Authorisation
The pre-market assessment process involves several steps, including evaluating technical documentation and clinical evidence and assessing labelling and manufacturing processes. The TGA may also conduct on-site inspections of manufacturing facilities to ensure compliance with regulatory requirements.
There are three types of pre-market assessments that medical devices may undergo in Australia:
- Conformity assessment certificates: This type of assessment involves an independent third-party organisation assessing the medical device against applicable standards to determine if it meets the Essential Principles for Safety and Performance. If the device meets the standards, a Conformity Assessment Certificate is issued, which can be used to support an application for ARTG listing.
- ARTG listing: All medical devices must undergo this assessment before being marketed in Australia. The TGA assesses technical documentation and clinical evidence to determine whether the device meets safety and performance standards. If the device is compliant, it is listed on the ARTG.
- Clinical evidence: As outlined above, the TGA may require additional clinical evidence for high-risk medical devices to support the application for ARTG listing. This may involve conducting clinical trials or providing expert opinions to demonstrate the effectiveness and safety of the device.
Key Requirements for Market Authorisation of Therapeutic Goods
Ensuring that your products meet the regulatory requirements allows you to obtain market authorisation and provide safe and effective therapeutic goods to Australian patients.
Applying for, obtaining, and costs associated with market authorisation will depend on the type and classification of your therapeutic good. The steps and level of information you must provide will also depend on your products’ risk level. There are three stages to the market authorisation process: pre-market, processing, and post-market.
Here are some key requirements for obtaining market authorisation for your therapeutic good:
- Application fee (the amount still depends on the type of your therapeutic good);
- Supporting data related to the quality, safety, and efficacy of your products;
- Compliance with the requirements for conformity assessments to demonstrate that the devices comply with the Essential Principles; and
- A TGA Business Services (TBS) account for your application.
Benefits of a Successful Pre-Market Assessment
The proper pre-market assessment to obtain market authorisation for your therapeutic products entail various benefits. Here are some of them:
- Assurance of the safety and efficacy of medical devices and therapeutic goods before they are marketed to the public;
- Proper identification of any potential risks associated with the product, allowing for necessary adjustments before the product is released;
- Increased consumer confidence in the safety and effectiveness of the product;
- Fair competition in the market by ensuring that all products meet the same regulatory standards;
- Prevention of fraudulent or misleading claims about the product, protecting consumers from harm; and
- Reduced product recalls, which can be costly for manufacturers and harmful to consumers.
Contact a Regulatory Medical Device Consultant!
Whether you’re a researcher developing innovative products or a manufacturer bringing a medical device or therapeutic good to the Australian market, having a comprehensive understanding of pre-market assessment by the TGA is essential so that you meet the approval requirements.
Hiring a medical device consultant to obtain market authorisation for medical device products is valuable. Vicki Partridge is a regulatory affairs consultant in Australia who can provide advice, specific assistance, and other regulatory-related services.
With her extensive industry knowledge, Viki can assist you in meeting all pre-market assessment requirements and ensure you fast-track your way to penetrating the Australian therapeutic goods market. Contact Vicki now at +61 7 55295508 to find out what it takes to be a legal supplier of therapeutic goods in Australia.